G9470 HCPCS Reimbursement & Policy Benchmarks | OpenPayer

Summary & Overview

HCPCS G9470: Documentation of Corticosteroid Exposure Status

HCPCS Level II code G9470 documents patients who are not receiving sustained corticosteroid therapy at or above specified prednisone-equivalent thresholds. The code captures two criteria: absence of corticosteroid doses ≥10 mg/day for 60 or more consecutive days, or absence of any single prescription totaling ≥600 mg prednisone across fills. Nationally, standardized tracking of corticosteroid exposure supports medication safety, quality measurement, and appropriate clinical decision-making for conditions where steroid-sparing strategies or infection risk assessments are relevant. Key payers in the national coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical intent of the code, typical service and site-of-care contexts, and what operational documentation is associated with its use. The publication summarizes benchmarks and policy-relevant considerations for billing and clinical teams, highlights where the code fits in quality measurement and medication management workflows, and clarifies gaps where data were not provided. Data not available in the input include specific payer policy details, associated taxonomies, and linked ICD-10 diagnoses.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9470HCPCS Level IIcorticosteroid exposuremedication reconciliationoutpatientquality measurementclinical documentationprednisone equivalent

Billing Code Overview

HCPCS Level II code G9470 indicates patients who are not receiving corticosteroids at doses greater than or equal to 10 mg/day of prednisone equivalents for 60 or more consecutive days, or who do not have a single prescription equating to 600 mg prednisone or greater for all fills. This code documents corticosteroid exposure status for a patient over a defined period.

Service type: Medication exposure documentation and clinical status assessment
Typical site of service: Outpatient clinic, ambulatory care, or other outpatient settings where medication history and chronic therapy assessments are performed

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.

Clinical & Coding Specifications

Clinical Context

A typical patient scenario involves an ambulatory adult with a chronic inflammatory or autoimmune condition (for example, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease exacerbation history, or inflammatory bowel disease) who is being evaluated for systemic corticosteroid exposure. The clinical workflow begins during a population health or medication reconciliation visit, preoperative evaluation, or quality reporting review. A clinician or clinic nurse documents medication history and confirms that the patient has NOT received systemic corticosteroids at or above a cumulative exposure threshold: at least 10 mg prednisone equivalent daily for 60 or more consecutive days, or a single prescription totaling 600 mg prednisone equivalent or greater across fills. Typical site of service is outpatient clinic, primary care, specialty rheumatology/pulmonology or preoperative testing clinic. Commonly the code G9470 is applied for quality measurement and reporting to indicate absence of prolonged/high-dose steroid exposure, supporting vaccine decisions, infection risk assessment, or perioperative steroid management. The typical patient scenario: a 56-year-old female with well-controlled rheumatoid arthritis seen in rheumatology clinic for routine follow-up; medication reconciliation confirms corticosteroids are not being taken at or above 10 mg prednisone daily for 60+ consecutive days and there are no prescriptions equivalent to 600 mg prednisone or greater — documentation is recorded and G9470 is used for reporting. Payors potentially involved include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare for measure or reporting considerations.

Coding Specifications

HCPCS G0057: Emergency Medicine Best Practices and Patient Safety

HCPCS-G9562-OPIOID-THERAPY-QUARTERLY-FOLLOW-UP-EVALUATION

HCPCS G9562: Follow-Up Evaluation During Opioid Therapy, Quarterly

HCPCS-G8461-HEPATITIS-C-ANTIVIRAL-TREATMENT

HCPCS G8461: Patient Receiving Antiviral Treatment for Hepatitis C

HCPCS-G8728-FASTING-LIPID-PROFILE-NOT-PERFORMED-NO-REASON

HCPCS G8728: Fasting Lipid Profile Not Performed, Reason Not Given

HCPCS-G9074-INVASIVE-BREAST-CANCER-STAGE-IIIA-IIIB-ER-PR-NEGATIVE

HCPCS G9074: Invasive Female Breast Adenocarcinoma, Stage IIIA–IIIB, ER/PR Negative

HCPCS-G9215-CD4-NOT-DOCUMENTED

HCPCS G9215: CD4+ Count Not Documented

HCPCS-G2205-PREGNANCY-DURING-ADJUVANT-TREATMENT

HCPCS G2205: Pregnancy During Adjuvant Treatment Course

HCPCS-G6051-FLURAZEPAM-OUTPATIENT-PHARMACY-DISPENSING

HCPCS G6051: Flurazepam, Outpatient Pharmacy Dispensing

HCPCS-G2103-SEVEN-FIELD-STEREOSCOPIC-FUNDUS-PHOTOGRAPHY-INTERPRETATION

HCPCS G2103: Seven-Field Stereoscopic Fundus Photography with Interpretation

HCPCS-G9631-URETER-INJURY-POST-SURGICAL-COMPLICATION

HCPCS G9631: Ureter Injury During or Within 30 Days After Surgery

Showing 1–10 of 1996

Modifier	Description	When to Use
`22`	Increased procedural services	Use when documentation supports substantially greater work or complexity associated with the evaluation or documentation related to steroid exposure assessment and counseling.
`23`	Unusual anesthesia	Generally not applicable to `G9470`; include only if an unrelated anesthesia event occurred during same encounter requiring reporting.
`52`	Reduced services	Use when the intended assessment or visit was partially performed, e.g., abbreviated medication reconciliation.
`53`	Discontinued procedure	Use if the clinical visit or assessment was started but terminated for patient safety or other documented reasons.
`54`	Surgical care only	Use when surgical services are billed separately and this evaluation pertains only to perioperative medication review by the surgeon.
`55`	Postoperative management only	Use when postoperative care includes documentation of steroid exposure but global surgical package exclusions apply.
`56`	Preoperative management only	Use when preoperative evaluation documents absence of prolonged/high-dose steroids and is billed separately from the surgery.
`62`	Two surgeons	Use when two surgeons are involved in care and modifiers are required for surgical claims that also include perioperative medication assessment.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery	Use when an advanced practice clinician documents steroid exposure as part of assistant-at-surgery services requiring modifier reporting.
`CO`	Left in raw data but not a CMS standard modifier — treat as informational	Use per payer-specific guidance if recognized by the payor.

Taxonomy Code	Specialty	Notes
`207R00000X`	Rheumatology	Rheumatologists commonly assess chronic steroid exposure for autoimmune disease management and quality reporting.
`207P00000X`	Pulmonology	Pulmonologists evaluate steroid exposure for severe asthma or COPD management and vaccination planning.
`261QM0800X`	Internal Medicine	Primary care/internal medicine clinicians perform medication reconciliation and longitudinal steroid surveillance.
`363L00000X`	Anesthesiology	Anesthesiologists or preoperative clinics may document steroid exposure as part of perioperative risk assessment.
`163WL0500X`	Surgical Specialties (General Surgery)	Surgeons and preoperative teams document steroid history relevant to wound healing and infection risk.

ICD-10 Code	Description	Clinical Relevance
Data not available in the input.	Data not available in the input.	Data not available in the input.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for the routine outpatient visit during which medication reconciliation documents absence of prolonged/high-dose corticosteroid exposure supporting `G9470` reporting.
`99406`	Smoking and tobacco use cessation counseling, intermediate, greater than 3 minutes up to 10 minutes	Example of a preventive counseling CPT that may be performed during the same visit when assessing infection risk and vaccine counseling related to steroid exposure.
`99497`	Advance care planning including the explanation and discussion of advance directives, first 30 minutes	May be performed in complex visits where medication risks including steroids are discussed; documents additional counseling time.
`99460`	Initial hospital care, per day, for the evaluation and management of normal newborn, not directly related but example of facility-based E/M	Data not directly related; included only as an example of facility E/M often paired with perioperative or inpatient medication reviews.
`G0438`	Annual wellness visit, initial, includes personalized prevention plan of service (PPPS)	Wellness visits include comprehensive medication review where `G9470` may be documented as part of preventive care reporting.

OpenPayer